Incorporation of lapatinib into core–shell nanoparticles improves both the solubility and anti-glioma effects of the drug

This publication has 29 references indexed in Scilit:

• Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles
  Nanotechnology, 2012
• Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
  Pharmaceutical Research, 2011
• Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma
  Biomaterials, 2011
• The Dual EGFR/HER2 Inhibitor Lapatinib Synergistically Enhances the Antitumor Activity of the Histone Deacetylase Inhibitor Panobinostat in Colorectal Cancer Models
  Cancer Research, 2011
• Three-Dimensional cryoEM Reconstruction of Native LDL Particles to 16Å Resolution at Physiological Body Temperature
  PLOS ONE, 2011
• Lactoferrin-Conjugated Biodegradable Polymersome Holding Doxorubicin and Tetrandrine for Chemotherapy of Glioma Rats
  Molecular Pharmaceutics, 2010
• Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect
  Journal of Controlled Release, 2010
• An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines
  Investigational New Drugs, 2009
• Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status
  Anti-Cancer Drugs, 2008
• Cationic Albumin–Conjugated Pegylated Nanoparticles Allow Gene Delivery into Brain Tumors via Intravenous Administration
  Cancer Research, 2006